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Abstract
Background: We consider the problem of designing a study to develop a predictive classifier from high
dimensional data. A common study design is to split the sample into a training set and an independent test set,
where the former is used to develop the classifier and the latter to evaluate its performance. In this paper we
address the question of what proportion of the samples should be devoted to the training set. How does this
proportion impact the mean squared error (MSE) of the prediction accuracy estimate?
Results: We develop a non-parametric algorithm for determining an optimal splitting proportion that can be
applied with a specific dataset and classifier algorithm. We also perform a broad simulation study for the purpose
of better understanding the factors that determine the best split proportions and to evaluate commonly used
splitting strategies (1/2 training or 2/3 training) under a wide variety of conditions. These methods are based on a
decomposition of the MSE into three intuitive component parts.
Conclusions: By applying these approaches to a number of synthetic and real microarray datasets we show that
for linear classifiers the optimal proportion depends on the overall number of samples available and the degree of
differential expression between the classes. The optimal proportion was found to depend on the full dataset size
(n) and classification accuracy - with higher accuracy and smaller n resulting in more assigned to the training set.
The commonly used strategy of allocating 2/3rd of cases for training was close to optimal for reasonable sized
datasets (n ≥ 100) with strong signals (i.e. 85% or greater full dataset accuracy). In general, we recommend use of
our nonparametric resampling approach for determing the optimal split. This approach can be applied to any
dataset, using any predictor development method, to determine the best split.
Background
The split sample approach is a widely used study design
in high dimensional settings. This design divides the col-
lection into a training set and a test set as a means of
estimating classification accuracy. A classifier is devel-
oped on the training set and applied to each sample in
the test set. In practice, statistical prediction models
have often been developed without separating the data
used for model development from the data used for esti-
mation of prediction accuracy [1]. When the number of
candidate predictors (p) is larger than the number of
cases as in microarray data, such separation is essential
to avoid large bias in estimation of prediction accuracy
[2]. This paper addresses the question of how to
optimally split a sample into a training set and a test set
for a high dimensional gene expression study, that is,
how many samples to allocate to each group.
Two approaches to evaluating splits of the data are
examined. The first approach is based on simulations
designed to understand qualitatively the relationships
among dataset characteristics and optimal split propor-
tions. We use these results also to evaluate commonly
used rules-of-thumb for allocation of the data to train-
ing and test sets. Our second approach involves devel-
opment of a non-parametric method that does not rely
on distributional assumptions and can be applied
directly to any existing dataset without stipulating any
parameter values. The nonparametric method can be
used with any predictor development method (e.g., near-
est neighbor, support vector machine).
This paper addresses the situation in which the
accuracy of a predictor will be assessed by its
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performance on a separate test set. An alternative
approach is to apply resampling-based methods to the
whole dataset. Because re-sampling strategies have
been commonly mis-used, often resulting in highly
biased estimates of prediction accuracy [2,3], many
journals and reviewers mis-trust cross-validation and
require validation on a sample not used for model
development. Another advantage of the split sample
method, particularly in large collaborative studies in
which multiple groups will be developing predictors, is
that the test set can be kept under “lock and key” by a
honest broker [4].
The question addressed in this paper has not to our
knowledge been addressed before. Sample splitting has
been addressed in other contexts, such as comparing
different k-fold cross validations [5] or developing hold
out estimation theory [6] and bounds on Bayes error
[7]. Mukherjee et al. [8], Fu et al. [9], and Dobbin and
Simon [10] developed methods for planning the size of
a training set, but these methods do not address the
allocation of cases in an existing dataset to training and
test portions. Since many gene expression based classi-
fiers are developed retrospectively, there is often little
control of the sample size.
In the next section we describe the parametric model-
ing approach and the nonparametric approach that can
be applied to specific datasets. We also present the
results of application of these methods to synthetic and
real world datasets. In the Conclusions section, recom-
mendations for dividing a sample into a training set and
test set are discussed.
Approach
The classifier taken forward from a split-sample study
is often the one developed on the full dataset. This
full-dataset classifier comes from combining the train-
ing and test sets together. The full-dataset classifier
has an unknown accuracy which is estimated by apply-
ing the classifier derived on the training set to the test
set. The optimal split will then be the one that mini-
mizes the mean squared error (MSE) with respect to
this full-dataset classifier. The MSE naturally penalizes
for bias (from using a training set smaller than n) and
variance.
MSE decomposition
In the supplemental material [Additional file 1: Supple-
mental Section 1.2], it is shown that under mild
assumptions the MSE is proportional to
MSE ∝ A + V + B. (1)
Here we have symbols A, V and B to depict the
decomposition, and these are used throughout the dis-
cussion below. Here is a description of each term in
Equation (1). Figure 1 shows the breakdown visually.
A = Accuracy Variance Term The first term in Equa-
tion (1) reflects the variance in the true accuracy of a
classifier developed on a training set T selected from
the full dataset S. Not all training sets T ⊂ S will result
in predictors with exactly the same accuracy. The varia-
tion in actual (true) accuracy among all these different
predictors is the A term.
V = Binomial Variance Term The second term in
Equation (1) is the variance in the estimated accuracy
that results from applying the classifier to the test set.
This is a binomial variance because the classifier devel-
oped for a specific training set has some fixed true accu-
racy (success probability), and there are n - t
independent samples represented in the test set.
B = Squared Bias Term The third term in Equation (1)
is the squared bias that results from using a classifier
that was developed on t training samples to estimate the
accuracy of a classifier which is developed on n samples.
Model-based simulations for high dimensional expression
profiles
With each sample is associated a p-dimensional vector
of log gene expression measurements, say x, which is
assumed to follow the multivariate normal distribution
with mean vector μ1 for class 1 and μ2 for class 2 and
common covariance matrix Σ. Of the p genes, m are
assumed differentially expressed with difference in mean
expression levels between classes of 2δ and the remain-
ing p-m genes are not differentially expressed. Extensive
simulations under a variety of conditions indicated that
the components of MSE depended on the separation of
the classes with regard to gene expression and this is
determined by the number of differentially expressed
genes, the degree of differential expression and the cor-
relation among the differentially expressed genes. In
general none of these quantities are known before
Figure 1 Conceptual Diagram. Diagram of mean squared error
decomposition.
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analyzing the data. However, we have attempted to uti-
lize extensive simulation results to understand the rela-
tionship between sample size, class separation and
splitting effectiveness in order to provide robust general
recommendations.
Our simulations use the compound covariate predictor
[11], with gene selection performed using the optimal
selection cutpoint algorithm described in Dobbin and
Simon [10]. We adjusted the method in Dobbin and
Simon [10] for predicting an optimal significance level
for gene selection to avoid assuming that the prevalence
of the classes is known.
The MSE as a function of splitting proportion is esti-
mated for each simulated dataset in the following way:
1. Given 2δ/s standardized fold change, m informa-
tive genes, dimension p, n samples available, and a
covariance matrix Σ, generate a dataset S from the
probability model. Randomly select R training sets of
size t. A grid of t values are evaluated for each total
sample size n.
2. For each t above, calculate the optimal signifi-
cance level cutoff a to use for gene selection [10].
3. Using the optimal a levels to select genes from
pooled variance t-tests, develop compound covariate
predictors (CCP) [11] for each training set.
4. For each classifier developed on a training set of
size t, apply the classifier to the corresponding test
set of size n-t and estimate the classification accu-
racy. Average estimates over the R replicates to
obtain the mean predicted accuracy estimate.
5. Develop a CCP classifier on the full dataset S of n
cases. Using the parameters used to generate S, the
true accuracy of the classifier developed on the full
dataset was computed from theory.
Simulation approach with empirical effect sizes and
covariance matrix from real microarray dataset
In order to simulate from a model reflecting more clo-
sely real microarray data, data were generated from




where μˆ and ˆ were
estimated from the dataset of Rosenwald et al. [12]. Spe-
cifically, ˆ = p · Diag(S) + (1 − p) · S where S is the sam-
ple covariance matrix (pooled over the classes), and
Diag(S) is a matrix of zeros except for the diagonal,
which is equal to the diagonal of S. The covariance
matrix was shrunk away from singularity using p = 0.90
and p = 0.60. Then, elements of μˆ were estimated
empirically as described in the table legend. Finally,
datasets were generated from the model.













where k is the
classification cutpoint [13]. Datasets were split to obtain
the test set/training set accuracy estimate. Empirical
MSE’s were calculated.
A method for determining the optimal sample split for a
particular dataset, which utilizes a nonparametric data re-
sampling approach
The nonparametric bootstrap method of estimating
standard error [14] was used to estimate the variance of
the performance of a predictor developed on a training
set of size t and applied to a test set of size n - t. In our
previous notation, this was A + V. Splitting was per-
formed prior to resampling in order to avoid overlap
between the training and test sets.
In order to estimate the squared bias term B we con-
sidered adopting learning curve methods [15], as used
previously in Mukherjee et al. [8]. Briefly, [8] uses a
parametric nonlinear least squares regression approach
that fits a learning curve model to datapoints of the plot
with training set size t on the x-axis and the estimated
error rate on the y-axis. Fitting a learning curve of the
form e = a + b/ta where e is the expected error and t is
the training set size (and a > 0), provides an estimate of
the asymptotic error rate (a), i.e., when t = ∞. However,
we found the parametric learning curve model for the
data often did not fit our simulated or real data ade-
quately. Also, estimation of the squared bias term B
does not require estimation of the asymptotic error (a),
but only the mean error rate for limited training sizes t
≤ n. So instead, we use a nonparametric smoothing
spline to fit the plot with the training sample size t on
the x-axis and the average error rate on the y-axis.
When the learning curve raw data were not monotone
(usually because the error rate had stopped decreasing
significantly relative to the noise level present), then we
used isotonic regression to force monotonicity of the
fitted curve.
The squared bias term is estimated as follows:
1. For fixed n, and for t = 10, 20,..., n - 10, randomly
divide the dataset into a training set and a test set
1,000 times.
2. For each t, develop a classifier on each of the
1,000 training sets and apply the classifier to the cor-
responding test set. For each t, calculate the mean
error rate w of these 1,000 classifiers.
3. Fit a smoothing spline or isotonic regression of w
on t using spline case weights 1/t. Adjust degrees of
freedom visually based on the smoothing spline plot.
4. For t = 10, 20,..., n, calculatewˆ(t), the fit-value
from the spline or isotonic regression of the error
rate on t.
5. Estimate the squared bias using [wˆ(n) − wˆ(t)]2.
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Results and Discussion
We applied the parametric method to high dimensional
multivariate normal datasets, while varying the para-
meter settings and the class prevalences. Results are
shown in Table 1 and [Additional file 1: Supplemental
Table S1]. We considered total samples of size n = 200,
n = 100 and n = 50. For example, when m = 50 genes
are informative and n = 200, then the optimal number
of samples for the training set (reading across the first
row of Table 1) is 170, 70 or more, 30 or more, and 20
or more for effect sizes of 0.5, 1.0, 1.5 and 2.0, respec-
tively. The “or more” in the last three training set sizes
indicates that training set sizes anywhere from the speci-
fied size up to 190 result in practically equivalent mean
squared error.
Several features are apparent in Table 1: (i) when the
achievable accuracy is not much greater than 50%, the
optimal split allocates the vast majority of samples to
the test set. In this circumstance, no good classifier is
possible so additional samples allocated to the training
set are wasted and detract from lowering the variance of
estimation in the test set; (ii) when the gene expression
profiles of the two classes are widely separated, e.g.,
with a large number of differentially expressed genes
and large effect sizes, small training sets are adequate to
develop highly effective classifiers. The MSE is flat in
this circumstance nor large test sets are needed.
[Additional file 1: Supplemental Table S1] shows the
results when the prevalence is unbalanced, namely, 2/3
from one class and 1/3 from the other class. The results
for this imbalanced prevalence setting are very similar
to the equal prevalence setting. This suggests that the
same general optimal splits apply for a range of class
prevalence (33% to 67%).
The relative sizes of the three terms contributing to
the mean squared error of Equation (1) for the scenarios
of Table 1 and [Additional file 1: Supplemental Table
S1] are shown in the Supplementary material [Addi-
tional file 1]. An example is shown in Figure 2. Gener-
ally, the A term tends to be relatively small across the
range of sample sizes.
The squared bias term B tends to be relatively large
for small sample sizes and to dominate the other terms.
When development of a good classifier is possible, the
actual accuracy of classifiers developed on the training
set may initially increase rapidly as the training set size
increases. As the sample size increases, the bias term B
decreases until no longer dominating. This is because
the accuracy of the classifier improves as the size of the
training set increases and approaches the maximum
accuracy possible for the problem at hand. The rate of
Table 1 Table of optimal allocations of the samples to
the training sets
Optimal number to training set
n = 200
Effect = 0.5 Effect = 1.0 Effect = 1.5 Effect = 2.0










































































Entries in table are
t
(Acc) where t is the optimal number for the training set
and Acc is the average accuracy for a training set of size n. Total sample size
is n. “DEG” is the number of independent differentially expressed genes.
“Effect” is the standardized fold change for informative genes (difference in
mean expression divided by standard deviation). Notation such as “50+”
indicates that the MSE was flat, achieving a minimum at t = 50 and remaining
at that minimum for t > 50. (Here, “flat” is defined as having a range of MSE
values less than 0.0001.) Data generated with dimension P = 22,000. Each
table entry based on 1,000 Monte Carlo simulations. Equal prevalence from
each of two classes.
Figure 2 Example of MSE decomposition . Example figure
showing the relative contributions of the three sources of variation
to the mean squared error. This is a scenario from one entry in
Table 1. Plots for all other scenarios associated with Table 1 and
[Additional file 1: Supplemental Table S1]. Here there is m = 1
informative gene, n = 200 total samples available for study, and the
standardized fold change for the informative gene is 2δ/s = 1.0.
Dobbin and Simon BMC Medical Genomics 2011, 4:31
http://www.biomedcentral.com/1755-8794/4/31
Page 4 of 8
decrease of the squared bias term B will depend some-
what on the type of classifier employed and on the
separation of the classes. When the classes are not dif-
ferent with regard to gene expression, learning is not
possible and B will equal zero for all training set sizes.
The binomial variance term V is generally relatively
small unless the test set becomes very small at which
point it often dominates. The exceptions to this general
rule are in cases where the prediction accuracy nears 1
for t <n, in which case this V term remains near zero
even as the test set size becomes small. Another partial
exception is when the full dataset accuracy is below
85%, when the binomial variance increases.
Figure 3 is a comparison of the two most common
rules of thumb for splitting a sample into a training set
and a test set. The figure compares 50% allotment to
the training set versus 67% allotment to the training set
for the equal prevalence case. Each scenario represented
in Table 1 is also present in Figure 3. The x-axis is the
average accuracy (%) for classifiers developed from the
full dataset of n samples. The y-axis is the excess error
from using a non-optimal split. The discussion is orga-
nized around the full dataset accuracy:
• When the achievable true accuracy using the full
dataset for training is very close to 1, both the 50%
allotment and the 67% allotment to the training set
result in similar excess error.
• When the achievable true full dataset accuracy is
moderate, say between 60% and 99%, then in several
cases, assigning 67% to the training set results in
noticeably lower excess error, while in other cases
the two allotment schemes are roughly equivalent.
• Finally, and not surprisingly, when the achievable
true full dataset accuracy is below 60% (shaded area
on graph), then allotment of 50% to the training set
is preferable.
In sum, this graph shows that allotment of 2/3 rds to
the training set is somewhat more robust than allotment
of 1/2 to the training set.
The nonparametric method was applied to simulated
datasets and the MSE estimates compared to the para-
metric approach. Agreement between the two was very
good [Additional file 1: Supplemental Section 4].
Table 2 and [Additional file 1: Supplemental Section
5] shows that the results are similar under an empiri-
cally estimated covariance matrix and distance between
the classes [16-18].
Table 3 shows the results of the application of the
nonparametric method to several real-world datasets.
Note that the rightmost two columns show the excess
error when 1/2 and when 2/3 rds are allotted to the
training set. For the Rosenwald et al. [12] dataset of dif-
fuse large B-cell lymphoma, we estimated the optimal
split for distinguishing between germinal-center B-cell-
like lymphoma from all other types. For this dataset of
n = 240 patient samples, the optimal split was 150 : 90,
with about two-thirds of the samples devoted to the
training set. The excess error (root mean square error
difference, RMSD) from the 2/3 rds to training set rule
of thumb is 0.001; as a comparison, the RMSD for a
simple binomial random variable (with p = 0.96)
between a sample size of 236 and 240 is also 0.001.
Hence, the excess error at t = 2n/3 is very small.
For the Boer et al. [19] dataset, the optimal split was
80 for the training set and 72 for the test set, so that
53% were used to train the classifier to distinguish nor-
mal kidney from renal cell carcinoma. The dramatic dif-
ference in gene expression between cancer and normal
tissues meant that a smaller training set size was needed
to develop a highly accurate classifier [Additional file 1:
Supplemental Section 6.3]. As a result, the 1/2 to train-
ing set rule of thumb is a little better than the 2/3 rds
to training split. That being said, the excess error when
2/3 rds ares used for training is only 0.004. For compari-
son, the RMSD of 0.004 is similar to the RMSD result-
ing from increasing the sample size from 142 to 152 in
simple binomial sampling (when p = 0.98).
For the Golub et al. [20] dataset, the optimal split was
40 for the training set and 32 for the test set, or 56% for
the training to distinguish acute lymphoblastic leukemia
Figure 3 Comparing two rules of thumb. Comparison of two
common rules-of-thumb: 1/2 the samples to the training set and 2/
3 rds of the samples to the training set. X-axis is the average
accuracy (%) for training sets of size n. “Excess error” on the y-axis is
the difference between the root mean squared error (RMSE) and
the optimal RMSE. Each point corresponds to a cell in Table 1. Gray
shading indicates scenarios where mean accuracy for full dataset
size is below 60%.
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from acute myologenous leukemia. This is another
example of two classes with dramatically different
expression profiles. Like the Rosenwald dataset, the 2/3
rds to training set rule resulted in smaller excess error
than the 1/2 rule.
To distinguish oligodendroglioma from glioblastoma
in the the Sun et al. [21] dataset required 40 for the
training set and 91 for the test set, or 31% for the
training set. This optimal training sample size was
somewhat smaller than expected. This appeared to be
due to the accuracy leveling off after t = 40 training
samples, while the variance terms increased monoto-
nely for t > 40. The multidimensional scaling plot for
these data [Additional file 1: Supplemental Section 6.4]
showed a pronounced separation into two groups of
cases - but these groups only partly corresponded to
the class labels. The two groups were found easily with
n = 40 samples, but the corresponding error rate was
relatively high because of the imperfect correlation
between the class labels and the two clusters in the
plots. One is left to speculate whether this pattern was
the result of real underlying biology, or artifacts such
as batch effects or sample labeling errors. In this case
it did appear that 40 samples in the training set was
adequate to achieve accuracy near the best possible
with the full n = 130 samples.
A possible explanation for the Sun et al. [21] dataset is
that the full dataset accuracy was relatively low. We
therefore investigated another dataset of van’t Veer et al.
[22] which also had low full dataset predictive accuracy
and found a similar pattern. As shown [Additional file 1:
Supplemental Section 6.5], the multidimensional scaling
plot of grade 1/2 lung tumors versus grade 3 lung
tumors showed two groups that did not match up with
the tumor grade labels. This non-normality within
groups may reflect underlying biological heterogeneity.
As can be seen in the table, the optimal training set pro-
portion is below 50% for this dataset as it was for the
Sun et al. dataset, suggesting that with lower accuracies
the setting is more complex and a single rule of thumb
may not be adequate.
The supplement provides figures related to the fitting
on the real datasets [Additional file 1: Supplemental Sec-
tion 6]. We found that for the application to the real-
world microarray datasets it was critical to perform at
least 1,000 bootstrap re-samplings and 1,000 sample
splits in order to obtain adequately de-noised MSE
curves over the range of sample sizes.
Conclusions
We have examined the optimal split of a set of samples
into a training set and a test set in the context of
Table 2 Empirically estimated effects and covariance
p Bayes Acc. n Prev. %t Full data Accuracy Opt. Vs. t = 2/3 Opt. Vs. t = 1/2
0.9 0.962 240 50% 58.3 0.961 0.001 0.002
0.6 0.861 240 50% 54.2 0.860 0.003 0.002
Simulation results based on empirical estimates of covariance matrix and effect sizes. Columns are: p is the weight on a diagonal matrix, Bayes Acc. is the
optimal accuracy possible, n is the total sample size, Prev. is the prevalence from the most prevalent group, %t is the optimal allocation proportion to training,
Full data Accuracy is the mean accuracy when n = 240, and Opt. vs t = 2/3 is the root mean squared difference (RMSD) for the optimal rule and the 2/3 rds-to-
training rule, and Opt vs t = 1/2 is the RMSD between the optimal rule and the 1/2-to-training rule. Sample covariance matrix S calculated from [12]. Effect sizes
are estimated by the Empirical Bayes method of [10] with effect sizes shrunk to 80% of the empirical size. We followed methods similar to those previously
proposed ([16], [17], [18]) to obtain non-singular covariance matrix estimates, namely ˆ = p · Diag(S) + (1 − p) · S, where diag(S) is a matrix of zero’s




where δˆ is a
vector of half-distances between the class means. The number of informative genes was selected to achieve realistic Bayes (optimal) accuracies, so that all other
gene effects were set to zero. Genes with largest standardized fold changes were selected as informative.
Table 3 Applications to real datasets
Dataset n Prevalence %t Full dataset accuracy Optimal vs. t = 2
3
rule Optimal vs. t = 1
2
rule
Rosenwald 240 52% 63% 0.96 0.001 0.002
Boer 152 53% 53% 0.98 0.004 2e-4
Golub 72 65% 56% 0.95 0.002 0.004
Sun 131 62% 31% 0.83 0.022 0.008
van’t Veer 117 67% 26% 0.78 0.004 0.001
Nonparametric bootstrap with smooth spline (or isotonic regression) learning curve method results [Additional file 1]. n is the total number of samples from the
two classes, and “Prevalence” is the prevalence of the majority class. %t is the percent of samples allocated to the training set under optimal allocation, t/n
·100%. “Full dataset accuracy” is the estimated mean accuracy on the full dataset of size n. “Optimal vs.
2
3
rule” is the difference between the root mean squared
error for an optimal training set allocation and for the “2/3 rds to training set” allocation rule. The rightmost column is for the “1/2 to training set” allocation rule.
Classes for datasets are: Germinal Center B-cell-like lymphoma versus other (Rosenwald et al., 2002), renal clear cell carcinoma primary tumor versus control
normal kidney tissue (Boer et al., 2001), acute myelogenous leukemia versus acute lymphoblastic leukemia (Golub et al., 1999), glioblastoma versus
oligodendroglioma (Sun et al., 2006), grade 1/2 versus grade 3 lung cancer (van’t Veer et al., 2002).
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developing a gene expression based classifier for a range
of synthetic and real-world microarray datasets using a
linear classifier. We discovered that the optimal propor-
tion of cases for the training set tended to be in the
range of 40% to 80% for the wide range of conditions
studied. In some cases, the MSE function was flat over a
wide range of training allocation proportions, indicating
the near-optimal MSE performance was easy to obtain.
In other cases, the MSE function was less flat, indicating
clearer optimal selection. In general, smaller total sam-
ple sizes led to a larger proportions devoted to the train-
ing set being optimal. Intuitively this is because for a
given degree of class separation, developing an effective
classifier requires a minimal number of cases for train-
ing and that number is a greater proportion of a dataset
with fewer total cases.
The number of cases needed for effective training
depends on the “signal strength” or the extent of separa-
tion of the classes with regard to gene expression. “Easy”
classification problems contain individual genes with
large effects or multiple independent genes with moder-
ately large effects. For such problems the potential clas-
sification accuracy is high (low Bayes error). The
number of training cases required for near optimal clas-
sification for such datasets is smaller and hence smaller
proportions devoted to the training set could be near
optimal (for n = 100 - 200).
We found that when the average true accuracy of a




− to − 1
3
training-to-test set split
resulted in near optimal MSE in all settings considered.
Based on careful analysis and interpretation of the
extensive simulations in the Appendix, we think that the
rule of thumb that assigns 2/3rds to the training set and
1/3rd to the test set performs well in such situations. A
separate Section in the Supplemental material describes
the reasoning behind this recommendation. Generally,
however, there will be uncertainty about the true full
sample accuracy achievable and we recommend that the
nonparametric resampling algorithm that we developed
be applied to determine the optimal split. In applying
this method the specific classifier of interest should be
used. Use of our non-parametric algorithm to determine
the optimal split, rather than one of the standard rules-
of-thumb provides protection against the intra-class
genomic heterogeneity that appears present in the Sun
and van’t Veer datasets.
Throughout the simulation studies, this paper has
focused on common classifiers which are expected to
perform well. Our simulation results should be applic-
able to the commonly used linear classifiers such as
diagonal linear discriminant analysis, Fisher linear discri-
minant analysis and linear kernel support vector
machines. However, there are many other types of clas-
sifiers that are currently being investigated. It is beyond
the scope of this manuscript to comprehensively exam-
ine the MSE patterns of training set size variation for all
these classifiers. The simulation results may not carry
over to radically different types of classifiers, which may
learn at a much different rate or have very different full
dataset accuracies than those examined here. It is
important not to over-interpret what is necessarily a
limited simulation study.
This paper focused on the objective of obtaining a
classifier with high accuracy. In some clinical contexts
other objectives may be more appropriate, such as esti-
mation of the positive and negative predictive values, or
area under the ROC curve. If the prevalence is approxi-
mately equal for each class, however, then a high overall
accuracy will be highly correlated with high negative
and positive predictive values and AUC, so the guide-
lines here are likely to carry over to these other metrics.
The population prevalence from each class can be an
important factor in classifier development. In this paper
we looked at equal prevalence from each class, and at
the case of 2/3 to 1/3 prevalence split in our simula-
tions. The real datasets had prevalences within this
range as well. In cases where there is significant preva-
lence imbalance between the classes (e.g., 90% versus
10%) there will often be a number of issues outside the
scope of this paper. To modify our method for that con-
text, one would need to address whether oversampling
from the under-represented class is needed, and whether
the cost of misallocation should differ by class.
We looked at a range of sample sizes from n = 50 to n
= 200. In practice, sample sizes of n = 50 are probably
too small to divide into a training set and a test set, and
a better design uses resampling methods to estimate the
classification accuracy instead. This study supports the
general advice to use resampling methods in small sam-
ple settings because in these settings our method indi-
cates that the MSE is generally minimized when most of
the samples are devoted to the training set, with a typi-
cal allocation of 40 to training and only 10 samples for
the test set. This will usually be inadequate except in
very preliminary exploratory studies. For example, even
if the observed classification accuracy in the test set is
10/10 = 100%, the 95% confidence interval for classifica-
tion accuracy is 69% - 100%.
The data based resampling method presented in this
paper can be used with any predictor development
method by making minor modifications to the algorithm
outlined in the Results.
Methods
Computations were carried out in C++ using a Borland
5 compiler and Optivec 5.0 vector and matrix libraries,
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and R version 2.6.1 (including R “stats” package for
smooth.spline and isoreg functions). Gene expression
data were obtained from the BRB ArrayTools Data
Archive for Human Cancer Gene expression (url: http://
linus.nci.nih.gov/BRB-ArrayTools.html), except for [20]
data which was retrieved from the Broad Institute web-
site (url: http://www.broad.mit.edu/cgi-bin/cancer/data-
sets.cgi). Data were normalized using MAS 5.0 and
median centering each array using either R or BRB
ArrayTools (developed by Dr. Richard Simon).
Additional material
Additional file 1: Article supplement. Contains additional tables,
figures, theoretical derivations and discussions.
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